Drugs News and Research

RSS

New anti-phage defense mechanism in bacteria protects their DNA, finds study

Researchers from Singapore-MIT Alliance for Research and Technology, MIT's research enterprise in Singapore, have discovered a new anti-phage defense mechanism found in some bacteria, which uses previously unknown features to protect their DNA.

6 May 2020

Study proposes novel training technique to reinforce significance of proper PPE use

Despite the use of personal protective equipment, reports show that many health care workers contracted the coronavirus disease, which raises substantial concerns about the effectiveness of the PPE.

6 May 2020

Study investigates potential use of metal catalysts to create drug discovery platform

The use of metals in drug delivery could offer major benefits, including allowing for lower dosages of a medication to achieve therapeutic effects.

6 May 2020

New trial platform could help evaluate potential therapies for Parkinson’s disease

Despite 30 years of research, not a single therapy has been found to successfully delay or stop the progression of Parkinson's disease.

6 May 2020

Scientists identify unexpected player that causes vision loss in patients with AMD

Scientists have identified an unexpected player in the immune reaction gone awry that causes vision loss in patients with age-related macular degeneration (AMD), according to a new study published today in eLife.

6 May 2020

The Role of Microphysiological Systems for Oncology and Stem Cell Research

In this interview, Dr. Nancy Allbritton from The Allbritton Lab talks to News-Medical and Life Sciences about the revolutionary technology and techniques for the application of new technologies for oncology and stem cell research.

From Pittcon 6 May 2020

Study examines the link between flavenoid-rich foods and risk of Alzheimer’s disease

Older adults who consumed small amounts of flavonoid-rich foods, such as berries, apples and tea, were two to four times more likely to develop Alzheimer's disease and related dementias over 20 years compared with people whose intake was higher, according to a new study led by scientists at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University.

6 May 2020

Antibiotic Resistance: The Patient Perspective

We discuss the impact of antibiotic-resistant infections on everyday life and the work that is being done to overcome this issue with Antibiotic Research UK.

From Bionow 6 May 2020

Study: Laws that punish substance use during pregnancy do more harm than good

A new study co-authored by a University of Central Florida researcher shows that laws that punish substance use during pregnancy actually do more harm than good.

6 May 2020

New alcohol-monitoring program reduces risk of rearrest

An innovative statewide alcohol-monitoring program that requires drunk drivers to be tested frequently for alcohol use significantly lowers the likelihood that participants will be rearrested or have probation revoked, according to a new RAND Corporation study.

6 May 2020

New study shows the importance of genetic testing in people with solid tumor cancers

A new Cleveland Clinic study demonstrates the importance of genetics evaluation and genetic testing for children, adolescents and young adults with solid tumor cancers

6 May 2020

Scientists gain new insight into the pathological mechanisms behind two neurodegenerative diseases

An international team led by Emory scientists has gained insight into the pathological mechanisms behind two devastating neurodegenerative diseases.

6 May 2020

UTA is developing supply chain to rapidly deliver COVID-19 drugs to Texas’ underserved patients

Working with artificial intelligence, a University of Texas at Arlington researcher is developing a rapid-response supply chain designed to quickly deliver COVID-19 medications, once they are available, to vulnerable urban populations in Texas.

6 May 2020

Is ACEI, ARB use linked to testing positive for COVID-19?

A new study published in the prestigious journal JAMA Cardiology in May 2020 reports that there is no association between the use of ACEIs/ARBs and testing positive for COVID-19. This supports current medical advice to continue using these drugs as indicated irrespective of the ongoing pandemic but indicates the need for more research to rule out any additional risk of severe illness due to these agents.

6 May 2020

Cat coronavirus drug shows promise for treatment of COVID-19

“They are strong drug candidates for the treatment of human coronavirus infections because they have already been successful in animals (cats),” writes the team. “The work here lays the framework for their use in human trials for the treatment of COVID-19.”

5 May 2020

Researchers show basic lymphatic vessel functionality is the same in mice and humans

In an international collaboration, researchers from Uppsala University have mapped the lymph node lymphatic vessels in mice and humans down to the level of individual cells.

5 May 2020

Study finds two FDA-approved drugs are promising against COVID-19

Korean researchers have screened 48 FDA-approved drugs against SARS-CoV-2, and found that two, that are already FDA-approved for other illnesses, seem promising.

5 May 2020

New study may facilitate personalized therapy for depression, other neurological disorders

Depression is the leading cause of disability worldwide, striking as many as one in four women and one in eight men in their lifetime.

5 May 2020

Russian scientists create humanized mice to test drugs and vaccines for COVID-19

Following the recent Coronavirus outbreak, almost three million people have been infected worldwide, whereas the death toll has already passed the 200,000 mark, according to official reports.

5 May 2020

Hydroxychloroquine shown to slow recovery for COVID-19 patients

As researchers try to piece together a therapeutic strategy against the ongoing COVID-19 pandemic, a recent retrospective study from Cleveland Clinic Abu Dhabi, assessed the Hydroxychloroquine's efficacy in increasing SARS-CoV-2 viral clearance, finding that it appeared to significantly slow viral clearance in mild to moderately ill COVID-19 patients.

5 May 2020

Drugs News and Research

New anti-phage defense mechanism in bacteria protects their DNA, finds study

Study proposes novel training technique to reinforce significance of proper PPE use

Study investigates potential use of metal catalysts to create drug discovery platform

New trial platform could help evaluate potential therapies for Parkinson’s disease

Scientists identify unexpected player that causes vision loss in patients with AMD

The Role of Microphysiological Systems for Oncology and Stem Cell Research

Study examines the link between flavenoid-rich foods and risk of Alzheimer’s disease

Antibiotic Resistance: The Patient Perspective

Study: Laws that punish substance use during pregnancy do more harm than good

New alcohol-monitoring program reduces risk of rearrest

New study shows the importance of genetic testing in people with solid tumor cancers

Scientists gain new insight into the pathological mechanisms behind two neurodegenerative diseases

UTA is developing supply chain to rapidly deliver COVID-19 drugs to Texas’ underserved patients

Is ACEI, ARB use linked to testing positive for COVID-19?

Cat coronavirus drug shows promise for treatment of COVID-19

Researchers show basic lymphatic vessel functionality is the same in mice and humans

Study finds two FDA-approved drugs are promising against COVID-19

New study may facilitate personalized therapy for depression, other neurological disorders

Russian scientists create humanized mice to test drugs and vaccines for COVID-19

Hydroxychloroquine shown to slow recovery for COVID-19 patients

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News